With this release, the Canadian Medical Association Journal (CMAJ) teases one of its newly published studies that appears to be great news for babies and their parents: the promise of relieving pain from vaccination. Specifically, the news release promotes the idea of educational videos (i.e. for managing infant pain), giving a baby sugar water, and — most effectively, according to a study — spreading lidocaine cream on a baby’s skin before a round of injections. The release would have benefited from a clearer description of what type of lidocaine was used (over-the-counter or one only available with a prescription?) and a discussion of harms and some numbers to back up the benefit claim.
Vaccines are easily a doctor’s most powerful tool in saving lives and preventing suffering, especially in young (and more susceptible) children. But they’re no fun for parents or their infants, because intense crying and pain is inevitable, and that might help explain why as many as 1 in 4 adults fear needles and 10% avoid vaccination out of that fear. The authors of the new CMAJ study, as well as those of previous studies, argue that there would be more compliance and better vaccination rates if this pain could be safely and reliably reduced. However, while lidocaine is most often used to numb sunburn, bug bites, and other skin pain, it also receives one of the FDA’s strongest warnings against its use on kids (though for teething pain, not topical skin creams).
No dollar signs here, though an over-the-counter tube of lidocaine cream usually costs under $10. We’re not sure from the release if an OTC cream was used or one of the proprietary, prescription-only products.
There were no absolute numbers included here, and that’s a big omission. The CMAJ study notes how, per a score of 1-10 on the Modified Behavioral Pain Scale (MBPS) — with 10 being the highest level of pain — an improvement of 0.6 is generally necessary for doctors to change their practice on a procedure. Yet the study showed that the absolute effect of lidocaine cream (plus an educational video and sugar water) on vaccination pain was less, at 0.5.
There’s also this: As noted in the comments at a NEJM Journal Watch post, it can take more than an hour for lidocaine creams to make pain relief effective for tissues deeper than the skin (and vaccines are often injected into muscles). For the CMAJ study only about 20 minutes elapsed, since the cream was applied right before parents watched a 20-minute video and taken off immediately afterward.
Potential harms weren’t addressed at all. While lidocaine is most often used to numb sunburn, bug bites, and other skin pain, the Mayo Clinic describes it as a last resort for relieving topical pain in kids under the age of 3. Lidocaine can be toxic when ingested by children when used for oral pain relief during teething. The FDA has tracked some cases of seizures and even death linked to use of the drug.
The release provides a good summary of the study describing it as a randomized controlled trial of 352 healthy infants who were randomized into four groups.
Although the study did not evaluate lidocaine cream alone as one of the four experiment groups, the release does note consistently that the lidocaine was given in combination with other treatment strategies.
We didn’t see anything that would cause a reader distress or blow the problem of vaccine injection pain out of proportion.
The release does note that Pfizer funded the research, but you’ll only see that listed on a sidebar of the EurekAlert!-hosted version of the news release. The disclosure isn’t included in the release text, meaning it probably won’t be noted in subsequent reprints of the release or many articles launched by the news release.
Perhaps more importantly, the release — unlike the study itself — doesn’t disclose that the lead author received a research grant from Pfizer, which makes a lidocaine-containing line of products called Lignocaine. This is an important consideration not only in terms of sponsorship transparency; it also raises the question of whether Lignocaine results can be generalized to other lidocaine products.
The release compares a range of methods for alleviating vaccination pain in infants — training parents on how to soothe a child, giving the child sugar water, and applying lidocaine cream. We’re not told the contents of the training video but presumably it focused on holding, verbal soothing and nursing. In its practice guidelines, the CMAJ recommends breastfeeding during a vaccine injection to mitigate pain in infants.
Lidocaine creams come in many different over-the-counter products but it’s unclear whether the lidocaine formulation used in the study is the same as one might find over-the-counter, or if it’s EMLA (a cream using equal parts lidocaine and prilocaine) or another prescription product.
A randomized controlled trial comparing different methods of pain relief (placebo control, the video, sugar water, and lidocaine in combination with the sugar water and video) appears to be a novel approach to studying pain relief in infants.
The release could have done a better job explaining why researchers chose to combine some methods but not test lidocaine alone. There is other published research available on treating “procedural pain” in infants and children, but these are mostly focused on venipuncture. There are many studies on sucrose (but almost all in neonates), some on other soothing actions (presumably what was in the video), and some on topical anesthetics. However, the intramuscular aspect of immunizations may make them different. Nonetheless, many pediatricians already use a topical agent (usually EMLA) for immunizations.
Nothing over-the-top here, though we feel the news release’s headline isn’t supported by the release itself, let alone the study.
Systematic, Criteria-Driven
Monday at #ADA2021, an infectious disease epidemiologist, a journalist, and a researcher shared perspectives on communication of risk in the era of COVID-19: http://ow.ly/ROfR30rMeE7 @AstleyCM @garyschwitzer @berthahidalgo @ADA_DiabetesPro
Shoutouts to @susan_bewley @drkevinknopf @MichaelBaum11 in this call for more than fawning coverage from press releases for these kinds of stories.
Also, linked history inside goes back 5 years just on Grail apparently trying to become Holy Grail. https://twitter.com/garyschwitzer/status/1408849696416841731
Comments (1)
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
raymond barnum
January 12, 2017 at 8:46 pmMany years ago I discovered that significant pressure on the injection site for 30 seconds or so, followed by firmly rubbing the surface with REAL gauze (the kind with the threads) would desensitize the injection site very effectively. Thousands of injections later (I’ve been around awhile…) it still works nicely.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like